XML 124 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Net loss $ (5,701,000) $ (6,681,000) $ (15,762,000) $ (33,061,000)  
Loss from discontinued operations (3,481,000) $ (3,481,000)
Loss from continuing operations (5,701,000) (6,681,000) (15,762,000) (29,580,000)  
Adjustments to reconcile net loss to net cash used by operating activities:          
Depreciation and amortization     1,692,000 4,150,000  
Loss (income) on equity method investment     (3,000) 28,000  
Loss on investments     1,021,000 4,292,000  
Change in ROU assets     556,000 749,000  
(Loss) gain on sale of assets     (165,000) 1,281,000  
Impairment of assets upon deconsolidation     6,220,000  
Provision for loan losses     1,627,000 4,936,000  
Decrease (increase) in assets:          
Accounts receivable     1,557,000 2,520,000  
Inventory     (488,000) 4,368,000  
Prepaid expenses and other current assets     (80,000) 323,000  
Other assets     (36,000) 2,448,000  
Increase (decrease) in liabilities:          
Accounts payable     (255,000) (2,896,000)  
Accrued expenses     (111,000) (15,549,000)  
Change in ROU liabilities     (511,000) (763,000)  
Other liabilities     1,777,000 (81,000)  
Net cash used by operating activities - continuing operations     (9,181,000) (17,554,000)  
Net cash used by operating activities - discontinued operations     (3,481,000)  
Net cash used by operating activities     (9,181,000) (21,035,000)  
Cash flows from investing activities:          
Purchase of property, plant and equipment     (29,000) (679,000)  
Purchase of investment     (1,861,000)  
Disposal of property, plant and equipment     5,140,000 215,000  
Sale of marketable securities     3,029,000 11,330,000  
Issuance of new notes receivable, net origination fees     (402,000) (400,000)  
Payments received on notes receivable     4,039,000 1,419,000  
Net cash provided by investing activities     9,916,000 11,885,000  
Cash flows from financing activities:          
Payments of long-term debt     (1,492,000) (4,056,000)  
Borrowings of long-term debt     3,546,000 813,000  
Issuances of common stock, net of issuance costs     2,227,000  
Net cash provided (used) by financing activities     4,281,000 (3,243,000)  
Net increase (decrease) in cash - continuing operations     5,016,000 (8,912,000)  
Net increase (decrease) in cash - discontinued operations     (3,481,000)  
Cash and cash equivalents at beginning of period     6,615,000 19,290,000 19,290,000
Cash and cash equivalents at end of period $ 11,631,000 $ 6,897,000 $ 11,631,000 $ 6,897,000 $ 6,615,000